Eric Shiozaki, PhD
InvestorFounderPartner at Revelation Partners · Partner at DCVC (Data Collective) · Board director at Auron Therapeutics
San Francisco, California, United States
Writes $5M – $50M checks
FoundedAuron Therapeutics
About
Eric Shiozaki’s background as a structural biologist (PhD in Molecular Biology, Princeton) combined with cross-stage investing in early biotech, late private and secondaries gives him panoramic biopharma and device insight.
Invests in
BiotechHealthtechMedical Devices
Board director at Auron Therapeutics
Intro paths
→
In turn, Eric can intro founders to Auron Therapeutics's investors below.
Auron Therapeutics's investors · 2
Co-founders at Auron Therapeutics
KY
Katharine YenExecutive Officer, Director
CG
Christopher GuiffreExecutive Officer
Experience
- Revelation PartnersPartnercurrent2025 — presentSan Francisco Bay Area
- Revelation PartnersVenture Partner2024 — 2025San Francisco Bay Area
- DCVC BioPartner2021 — 2024San Francisco Bay Area
- Novo HoldingsPartner - Novo Ventures2018 — 2021San Francisco Bay Area
- Novo HoldingsPrincipal - Novo Ventures2014 — 2017San Francisco Bay Area
- Apposite CapitalDirector2011 — 2014San Francisco Bay Area
- Apposite CapitalAssociate Director2009 — 2011San Francisco Bay Area
- VitaPath GeneticsDirector of Corporate Development & Strategy2009San Francisco Bay Area
- Burrill & CompanyAssociate2007 — 2008San Francisco Bay Area
- Burrill & CompanyIntern2007San Francisco Bay Area
- University of California, Los AngelesTechnology Transfer Associate2006 — 2007Los Angeles
- University of California, Los AngelesLeukemia & Lymphoma Society Postdoctoral Fellow2004 — 2007Los Angeles
- Princeton UniversityPostdoctoral Researcher2003 — 2004Princeton, New Jersey, United States
Education
- Princeton UniversityPh.D., Molecular Biology1999 — 2003
- The Johns Hopkins UniversityBA, Biophysics1996 — 1999
Skills & more
Management2Strategy12Biotechnology8Venture Capital27Technology Transfer9Medical Devices6Investments8Start-ups20Entrepreneurship10Due Diligence10Corporate Development9Portfolio Management2
+12 more
Corporate FinanceMergers & AcquisitionsFinancePrivate EquityProtein ChemistryLifesciencesGeneticsDrug DiscoveryBusiness DevelopmentLife SciencesPharmaceutical IndustryValuationFrom Eric's professional profile.
Colleagues at Revelation Partners
Chris Bayliss
Vice President at Revelation Partners
Colleen Hochberger
Manager, Marketing & Operations at Revelation Partners
Doug Fisher
Partner, MD at Revelation Partners
Doug Fisher, MD
Partner at Revelation Partners
Fred Lee
Partner at Revelation Partners
Garrett Brown
Senior Associate at Revelation Partners
Jonathan Au
Partner at Revelation Partners
Jordan Bloom
Associate at Revelation Partners
Network11
Alan CohenScout
General Partner at DCVC (Data Collective)
Ali TamasebScout
General Partner at DCVC (Data Collective)
Chris BoshuizenScout
Partner at DCVC (Data Collective)
James HardimanScout
General Partner at DCVC (Data Collective)
Jason PontinScout
General Partner at DCVC (Data Collective)
Anna Fokina
Investment Director DCVC Bio at DCVC (Data Collective)
Daniel Coley
Associate at Cofounders Capital
Irfan Ahmad
Investor at DCVC (Data Collective)
Jack Buendorf
Investor at DCVC (Data Collective)
Jeremy Joseph
Investor at DCVC (Data Collective)
Joe Oleynik
Investor at DCVC (Data Collective)
Investors connected to Eric in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Eric Shiozaki, PhD work?
- Eric Shiozaki, PhD is Partner at Revelation Partners and Founder at Auron Therapeutics.
- What does Eric Shiozaki, PhD invest in?
- Eric Shiozaki, PhD invests in Biotech, Healthtech, Medical Devices.
- What check size does Eric Shiozaki, PhD write?
- Eric Shiozaki, PhD typically writes checks of $5M – $50M.
- What companies did Eric Shiozaki, PhD found?
- Eric Shiozaki, PhD founded Auron Therapeutics.
Same school
Also attended Princeton University551
Fabrice GrindaCo-founder & Managing Partner at FJ LabsAndrewAdvisor at Clear VenturesChristal NgAssociate at Golden Gate VenturesDavid CoatsManaging Director & Co-Founder at Correlation VenturesDan MoreheadFounder & CEO at Pantera CapitalHoward CoxSpecial Limited Partner at Greylock Partners
.jpg)
.png)
+ 545 more
Also attended The Johns Hopkins University245
Wes NicholsPartner at March Capital PartnersDemi ObayomiPrincipal at Sapphire VenturesJun JeonInvestor at Khosla VenturesNicole FraenkelInvestor at Khosla VenturesElena VibochManaging Director at General CatalystScott RubinVenture Partner at Lux Capital
+ 239 more
Shared employers
Also worked at Revelation Partners12
Prashant GangwalChief Financial Officer at Altos Ventures at 1809 CapitalMike BoggsManaging Partner at Revelation PartnersJonathan AuPartner at Revelation PartnersDoug Fisher, MDPartner at Revelation PartnersFred LeePartner at Revelation PartnersLiz StaleyPartner & Chief Compliance Officer at Revelation Partners
+ 6 more
Also worked at DCVC Bio5
John HamerManaging Partner, DCVC Bio at DCVC (Data Collective)Kiersten SteadManaging Partner, DCVC Bio at DCVC (Data Collective)Christopher MeldrumEntrepreneur In Residence, DCVC Bio at DCVC BioAimee VillamayorOffice Manager & Executive Assistant, DCVC Bio at DCVC BioLuca ParolariSenior Associate at DCVC (Data Collective)
Also worked at Novo Holdings24
Jeffrey LowPartner at Averin CapitalYip Hon MunChair at Tiger 21 at Orbit StartupsPeter EckesOperational Partner at Astanor VenturesJack NielsenManaging Partner at Vivo CapitalHenrijette RichterManaging Partner at Sofinnova PartnersAaron NelsonManaging Director at Novartis Venture Fund
+ 18 more
